BioCentury
ARTICLE | Company News

Atrix, Immune Network deal

August 12, 2002 7:00 AM UTC

IMMFF received non-exclusive access to ATRX's preclinical data related to dapsone, an antimicrobial and anti-inflammatory therapeutic. ATRX is in Phase III testing of its Atrisone topical dapsone for...